Results 171 to 180 of about 22,974 (229)

Outcomes of obesity medications in those with low response to a low-energy diet meal replacement programme: An observational study. [PDF]

Obes Pillars
Shand J, Jiang Y, Murphy R.
europepmc   +1 more source

Investigating pharmacotherapies for alcohol use disorder using Drosophila melanogaster. [PDF]

Alcohol Clin Exp Res (Hoboken)
Oramas R, Jaques Y, D'Silva NM, Azanchi R, McGeary JE, Kaun KR.   +5 more
europepmc   +1 more source

Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis

, 1993
Marco Bertolotti, Anna Ferrari, Tommaso Trenti, Giovanni Vitale, Teodora Macchia, Carullin, E Sternieri   +6 more
openalex   +1 more source

Effect of varenicline on major adverse liver outcomes in alcohol-associated liver disease: An exploratory analysis. [PDF]

Alcohol Clin Exp Res (Hoboken)
Danpanichkul P, Pang Y, Kim D, Suenghataiphorn T, Ko D, Ibrahim AF, Prasitsumrit V, Duangsonk K, Noureddin M, Wijarnpreecha K, Liangpunsakul S.   +10 more
europepmc   +1 more source

Efficacy of naltrexone and bupropion combination in patients with binge eating disorder: a systematic review and meta-analysis. [PDF]

Eat Weight Disord
Roudbaraki SN, Salimi M, Esmailpour S, Mohammadi F.   +3 more
europepmc   +1 more source

Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies. [PDF]

Cureus
Raza SS, Zakir Z, Hashmat A, Awan SK, Varrassi G.   +4 more
europepmc   +1 more source

Assessing Cravings Among Individuals with Alcohol Dependence Syndrome Prescribed with Anti-craving Medication: A Prospective Observational Study. [PDF]

Indian J Psychol Med
Sultana M, Verma T, Jose A, Gopal Das Cm, Neeraj Raj B.   +4 more
europepmc   +1 more source

Combined Naltrexone-Bupropion Therapy for Concurrent Cocaine Use Disorder and Obesity: A Case Report. [PDF]

Reports (MDPI)
Romeo VM.
europepmc   +1 more source

Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial. [PDF]

J Clin Psychiatry
Jha MK, Ghitza UE, Shoptaw S, Minhajuddin A, Kuruvila S, Wakhlu S, Nunes EV, Schmitz J, Coffin PO, Bart G, Carmody T, Trivedi MH.   +11 more
europepmc   +1 more source

Comments on "Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis". [PDF]

Korean J Pain
Doan HN, Kwak SG, Chang MC.
europepmc   +1 more source